HX GROUP(SH:600851) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-10-17 00:49Core Viewpoint - The company has approved a strategic plan for 2026-2030 to adapt to macroeconomic changes and technological transformations, aiming to strengthen its market position and drive growth [1][2]. Group 1: Board Meeting Details - The board meeting was held on October 15, 2025, in Shanghai, with all 9 directors present, including participation via communication methods [1]. - The meeting was chaired by Chairman Deng Haibin, with all senior executives in attendance [1]. Group 2: Strategic Planning - The strategic plan focuses on two main growth curves: enhancing the existing pharmaceutical business through management improvements and acquisitions, and exploring new opportunities for innovation and development [2]. - The property management sector will continue to operate steadily, contributing stable cash profits to support both growth curves [2]. - The company aims to achieve high-quality development and continuous value growth through a dual strategy of "industrial operation + investment and mergers" [2].